Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Rustin

Showing results (121-130 of 156) with videos related to

Pageof 16
Sort By:
Lancet (London, England)|August 24, 1991
Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapyD B Smith, E S Newlands, G J Rustin, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
A phase I/II study of the 5-HT3 antagonist GR38032F in the anti-emetic prophylaxis of patients receiving high-dose cisplatin chemotherapyD B Smith, E S Newlands, G J Rustin, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|December 2, 1998
The management of high-risk gestational trophoblastic tumours (GTT)E S Newlands, M Bower, L Holden, et al.
Thorax|December 1, 1983
Effective treatment for malignant mediastinal teratomaD Parker, C P Holford, R H Begent, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1997
EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patientsM Bower, E S Newlands, L Holden, et al.
British Journal of Cancer|February 1, 1990
Ondansetron (GR38032F) plus dexamethasone: effective anti-emetic prophylaxis for patients receiving cytotoxic chemotherapyD B Smith, E S Newlands, O W Spruyt, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1986
Is ectopic production of human chorionic gonadotrophin (hCG) or alpha fetoprotein (AFP) by tumours a marker of chemosensitivity?S M Crawford, J A Ledermann, W Turkie, et al.
British Journal of Cancer|December 1, 1988
Bone disease in testicular and extragonadal germ cell tumoursR N Hitchins, P A Philip, B Wignall, et al.
The British Journal of Surgery|January 1, 1982
The role of abdominal surgery in the treatment of advanced testicular germ cell tumoursB M Jones, E S Newlands, R H Begent, et al.
The Journal of Reproductive Medicine|March 26, 1998
Management of resistant gestational trophoblastic tumorsE S Newlands, M Bower, L Holden, et al.
Pageof 16

Showing results (121-130 of 156) with videos related to

Sort By:
Pageof 16
Lancet (London, England)|August 24, 1991
Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapyD B Smith, E S Newlands, G J Rustin, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
A phase I/II study of the 5-HT3 antagonist GR38032F in the anti-emetic prophylaxis of patients receiving high-dose cisplatin chemotherapyD B Smith, E S Newlands, G J Rustin, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|December 2, 1998
The management of high-risk gestational trophoblastic tumours (GTT)E S Newlands, M Bower, L Holden, et al.
Thorax|December 1, 1983
Effective treatment for malignant mediastinal teratomaD Parker, C P Holford, R H Begent, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1997
EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patientsM Bower, E S Newlands, L Holden, et al.
British Journal of Cancer|February 1, 1990
Ondansetron (GR38032F) plus dexamethasone: effective anti-emetic prophylaxis for patients receiving cytotoxic chemotherapyD B Smith, E S Newlands, O W Spruyt, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1986
Is ectopic production of human chorionic gonadotrophin (hCG) or alpha fetoprotein (AFP) by tumours a marker of chemosensitivity?S M Crawford, J A Ledermann, W Turkie, et al.
British Journal of Cancer|December 1, 1988
Bone disease in testicular and extragonadal germ cell tumoursR N Hitchins, P A Philip, B Wignall, et al.
The British Journal of Surgery|January 1, 1982
The role of abdominal surgery in the treatment of advanced testicular germ cell tumoursB M Jones, E S Newlands, R H Begent, et al.
The Journal of Reproductive Medicine|March 26, 1998
Management of resistant gestational trophoblastic tumorsE S Newlands, M Bower, L Holden, et al.
Pageof 16